Drug Pricing

House lawmakers recently introduced legislation that would at last repair a program meant to provide low-income Americans with affordable medicine. In theory, the federal 340B Program, named after the section of the 1992 law establishing it, allows hospitals serving underprivileged groups to buy medications at steep discounts. The idea was ...

There’s never been a better time to get lung cancer in the United States. That may sound morbid. But this deadliest of cancers appears to be losing a bit of its punch. The combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over ...

Wouldn’t it be nice if we didn’t have to pay for the things we want? That’s the long and short of U.S. Sen. Bernie Sanders’ latest harebrained scheme to cut drug prices. In the Vermont independent’s capacity as chairman of the Senate Health, Education, Labor and Pensions Committee, Sanders sent ...

Every day, nearly 10,000 people in the United States are diagnosed with skin cancer. The good news is that applying sunscreen can substantially reduce a person’s risk of getting skin cancer. The bad news is that the federal government is doing its best to keep effective sunscreens out of the hands of ...

For years, the left’s campaign to dictate the price of prescription drugs has focused on one medicine above all others — insulin. The hormone was discovered more than a century ago by Canadian doctor Frederick Banting and his medical student Charles Best. They famously sold their patent to the University of ...

Earlier this year, European authorities recommended approval of tofersen, a new drug that treats a rare genetic form of amyotrophic lateral sclerosis, or ALS. That decision came nearly a year after American regulators granted the drug accelerated approval. Patients with that rare form of ALS in England aren’t so lucky. The National Institute for ...

Last month at a White House event, President Joe Biden and Sen. Bernie Sanders, I-Vt., took a victory lap for supposedly having “beat Big Pharma” through drug-pricing provisions in the Inflation Reduction Act. Beaming with pride, they hailed new powers for Medicare to “negotiate” drug prices as a historic achievement. But their self-congratulation rests ...

SACRAMENTO – A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute analyzes a Journal of the American Medical Association (JAMA) study cited by Sen. Bernie Sanders (I-Vermont) to justify drug price controls, finding it was deeply flawed and would put ...

Cost Plus Drug Company CEO Mark Cuban recently pointed out that self-insured businesses could save over $70,000 per employee annually by getting their workers to switch from AbbVie’s blockbuster anti-inflammatory treatment Humira to a lower-cost biosimilar called Yusimry. Humira has a list price of roughly $7,000 per month. Since it lost market exclusivity last year, nine nearly identical copycats have hit ...

Following an enormous cyberattack on a subsidiary of UnitedHealth Group, the Senate Finance Committee has called the company’s CEO, Andrew Witty, to testify on April 30th. The hackers stole millions of medical records, which reflects badly on the company’s ability to protect patients. But while members of Congress are grilling Witty about the ...